[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355355-105":59,"doc-detail-355355-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","diagnostic-accuracy-and-clinical-utility-of-salivary-biomarkers-in-oral-squamous-cell-carcinoma-a-meta-analysis","Diagnostic Accuracy and Clinical Utility of Salivary Biomarkers in Oral Squamous Cell Carcinoma: A Meta-Analysis","","Salivary biomarkers show moderate diagnostic accuracy and limited clinical utility for oral squamous cell carcinoma (OSCC) when used as complementary tools. Following PRISMA and registered in PROSPERO, the study pooled data from 18 diagnostic accuracy studies (1647 participants; 45 datasets) across multiple biomarker classes. Results indicate pooled sensitivity of 0.64 and specificity of 0.71, with moderate heterogeneity and an AUC of 0.75. Fagan’s analysis supports use only in enriched populations (pretest probability >10%), not general screening.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/diagnostic-accuracy-and-clinical-utility-of-salivary-biomarkers-in-oral-squamous-cell-carcinoma-a-meta-analysis/355355/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/diagnostic-accuracy-and-clinical-utility-of-salivary-biomarkers-in-oral-squamous-cell-carcinoma-a-meta-analysis/355355.png","ImageObject",300,407,{"name":92,"@type":93},"Jake","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-15","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main diagnostic performance of salivary biomarkers for OSCC in this meta-analysis?","Question",{"text":113,"@type":114},"The pooled sensitivity is 0.64 and pooled specificity is 0.71, indicating moderate diagnostic accuracy with considerable heterogeneity.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Why are these biomarkers considered limited for general population screening?",{"text":118,"@type":114},"Fagan’s nomogram analysis shows they are not suitable for screening the general population, because clinical utility is context-dependent and requires an enriched baseline probability.",{"name":120,"@type":111,"acceptedAnswer":121},"In which patient populations are salivary biomarkers most appropriate according to the study?",{"text":122,"@type":114},"They should be reserved for enriched populations with a baseline OSCC probability greater than 10%, where they can serve as complementary triage tools rather than definitive diagnostics.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},355355,1790653862,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},962084928904,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Systematic Review  \nDiagnostic Accuracy and Clinical Utility of Salivary Biomarkers in Oral Squamous Cell Carcinoma: A Meta-Analysis  \nArbi Wijaya 1,2, Vera Julia 1, *, Nurtami Soedarsono 3, Lilies D. Sulistyani 1, Moh Adhitya Latief 1, Turmidzi Fath 3, Bayu Brahma 4, Alif Rizqy Soeratman 4, Denni Joko Purwanto 4, Yutaro Higashi 2 and Tsuyoshi Sugiura 2  \nAcademic Editors: Joanna Katarzyna Strzelczyk and Michal Masternak  \nReceived: 5 February 2026  \nRevised: 20 February 2026  \nAccepted: 12 March 2026  \nPublished: 17 March 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Oral & Maxillofacial Surgery, Faculty of Dentistry, Universitas Indonesia, Jakarta 10430, Indonesia; [arbi.wijaya.t2@dc.tohoku.ac.jp](arbi.wijaya.t2@dc.tohoku.ac.jp) (A.W.)  \n2 Division of Oral and Maxillofacial Oncology and Surgical Sciences, Graduate School of Dentistry, Tohoku University, Sendai 980-0872, Miyagi, Japan  \n3 Department of Oral Biology, Faculty of Dentistry, Universitas Indonesia, Jakarta 10430, Indonesia  \n4 Division of Surgical Oncology, Dharmais National Cancer Center Hospital, Jakarta 11420, Indonesia  \n* [Correspondence: vera.julia@ui.ac.id](Correspondence: vera.julia@ui.ac.id)  \nSimple Summary  \nSalivary biomarkers demonstrate moderate diagnostic accuracy and limited clinical utility when applied as complementary tools for OSCC classification in high-prevalence settings where the pre-test probability exceeds 10% . Their overall performance supports a role in their use as risk-stratification instruments in carefully selected patient populations, rather than as stand-alone diagnostics or screening tests for the general population. Notably, these biomarkers exhibit greater detection capacity. The test has greater inclusion than exclusion, meaning it is more effective at identifying potentially positive cases than at reliably ruling out disease. As a consequence, capacity and post-test probabilities remain clinically concerning even after a negative result, particularly in high-risk individuals and high-risk patients.  \nAbstract  \nBackground: Oral squamous cell carcinoma (OSCC) remains a major global health burden due to delayed diagnosis. Although salivary biomarkers have been explored in previous meta-analyses, these studies were limited to specific biomarker types. Methods: This study followed PRISMA guidelines and was registered in PROSPERO (CRD 420261296936) . PubMed, Scopus, MEDLINE, and CINAHL were searched for diagnostic accuracy studies of salivary biomarkers for OSCC. Studies providing sufficient data to construct 2 × 2 tables were included. Pooled sensitivity, specificity, DOR, and HSROC curves were estimated using a bivariate random-effects model, and study quality was assessed using QUADAS-2 . Results: Eighteen studies comprising 1647 participants yielded 45 diagnostic datasets across multiple biomarker classes. The pooled sensitivity and specificity were 0.64 (95% CI: 0.59–0.69) and 0.71 (95% CI: 0.66–0.76), respectively. The pooled DOR was 4.53 (95%  \nCI: 3.18–6.47), indicating moderate discriminatory ability, with an AUC of 0.75 (95% CI: 0.71–0.79) . Fagan’s nomogram analysis demonstrated that these biomarkers are not suitable for screening the general population and should be reserved for enriched populations (pretest probability > 10%) . Conclusions: Salivary biomarkers demonstrate moderate but highly heterogeneous diagnostic accuracy. Clinical utility is context-dependent and limited to enriched populations with a baseline probability of OSCC >10% . In screening the general population (prevalence \u003C 0.01%), these tests offer no significant clinical utility. They should be considered complementary triage tools rather than definitive diagnostic modalities.  \nKeywords: oral squamous cell carcinoma; saliva; biomarkers; diagnostic accuracy; sensitivity","cbCaiu4cmDbcYZS0","https://ap.wps.com/l/cbCaiu4cmDbcYZS0","pdf",4869111,27,"English","# Simple Summary\n# Abstract\n# 1. Introduction","[{\"question\":\"What is the main diagnostic performance of salivary biomarkers for OSCC in this meta-analysis?\",\"answer\":\"The pooled sensitivity is 0.64 and pooled specificity is 0.71, indicating moderate diagnostic accuracy with considerable heterogeneity.\"},{\"question\":\"Why are these biomarkers considered limited for general population screening?\",\"answer\":\"Fagan’s nomogram analysis shows they are not suitable for screening the general population, because clinical utility is context-dependent and requires an enriched baseline probability.\"},{\"question\":\"In which patient populations are salivary biomarkers most appropriate according to the study?\",\"answer\":\"They should be reserved for enriched populations with a baseline OSCC probability greater than 10%, where they can serve as complementary triage tools rather than definitive diagnostics.\"}]","Diagnostic Accuracy and Clinical Utility of Salivary Biomarkers in Oral Squamous Cell Carcinoma: A Meta-Analysis | PDF",1790118028,68,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1c007a8e86bc56f2dfc6f099e5746aca.webp",983,1390,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/29a023b7c764ab2fdb03546cdbfa1799.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2b2d500914c15684104be106a1352f82.webp",981,1387,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b1eb634f025714078896fbf3c1da255b.webp",980,1385]